APA

Rakhit A., Yeon M. M., Ferrante J., Fettner S., Nadeau R., Motzer R., Bukowski R., Carvajal D. M., Wilkinson V. L., Presky D. H., Magram J. & Gately M. K. (19990709). Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. : Clinical pharmacology and therapeutics.

Chicago

Rakhit A, Yeon M M, Ferrante J, Fettner S, Nadeau R, Motzer R, Bukowski R, Carvajal D M, Wilkinson V L, Presky D H, Magram J and Gately M K. 19990709. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. : Clinical pharmacology and therapeutics.

Harvard

Rakhit A., Yeon M. M., Ferrante J., Fettner S., Nadeau R., Motzer R., Bukowski R., Carvajal D. M., Wilkinson V. L., Presky D. H., Magram J. and Gately M. K. (19990709). Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. : Clinical pharmacology and therapeutics.

MLA

Rakhit A, Yeon M M, Ferrante J, Fettner S, Nadeau R, Motzer R, Bukowski R, Carvajal D M, Wilkinson V L, Presky D H, Magram J and Gately M K. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. : Clinical pharmacology and therapeutics. 19990709.